[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369938-105":59,"doc-detail-369938-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cancerimmune-coevolution-dictated-by-antigenic-mutation-accumulation","Cancer–immune coevolution dictated by antigenic mutation accumulation","","The immune system provides early defence against cancer, while tumour cells can evolve antigenic escape or inhibition of effector responses. This research develops an individual-based, stochastic model of mutation accumulation in cancer populations, explicitly coupling cancer–effector-cell interactions with random mutational effects that shape population expansion and extinction. The framework links interaction parameters to tumour progress outcomes, including suppression and evasion. It further predicts selection signatures in sequencing-derived statistics, especially single-cell mutational burden distributions, enabling bulk and single-cell sequencing to infer coevolutionary dynamics.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cancerimmune-coevolution-dictated-by-antigenic-mutation-accumulation/369938/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cancerimmune-coevolution-dictated-by-antigenic-mutation-accumulation/369938.png","ImageObject",300,407,{"name":92,"@type":93},"Well Done","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What core question does the study address about cancer and immunity?","Question",{"text":112,"@type":113},"How interactions between cancer cells and immune effector cells evolve during tumour development, specifically whether they leave measurable genetic signatures.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the model describe tumour–immune dynamics?",{"text":117,"@type":113},"It uses an individual-based model that accumulates random cancer mutations and explicitly couples cancer and effector cell interactions, including stochastic effects relevant to small populations.",{"name":119,"@type":110,"acceptedAnswer":120},"What evidence does the study propose from sequencing data?",{"text":121,"@type":113},"It predicts selection signatures in sequencing-derived summary statistics, such as the single-cell mutational burden distribution, implying bulk and single-cell sequencing can inform coevolutionary dynamics.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369938,1790228895,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},5909892210082,"https://ap-avatar.wpscdn.com/avatar/56001069da27c9f41e8?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789614185077863061","RESEaRCh aRTICLE  \n*For correspondence:  \n[weini.huang@qmul.ac.uk](weini.huang@qmul.ac.uk)  \nCompeting interest: The authors declare that no competing interests exist.  \nFunding: See page 14  \nPreprint posted  \n24 September 2024  \nSent for Review  \n18 November 2024  \nReviewed preprint posted  \n16 April 2025  \nReviewed preprint revised  \n26 August 2025  \nVersion of Record published  \n10 October 2025  \nReviewing Editor: Wenying Shou, University College London, United Kingdom  \n Copyright Wang et al. This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use andredistribution provided that the original author and source are credited.  \nCancer–immune coevolution dictated by antigenic mutation accumulation  \nLong Wang1,2, Christo Morison2, Weini Huang1,2*  \n1Group of Theoretical Biology, Innovation Center for Evolutionary Synthetic Biology School of Life Sciences, Sun Yat-sen University, Guangzhou, China; 2School of Mathematical Sciences, Queen Mary University of London, London, United Kingdom  \n\n| eLife Assessment\u003Cbr>This important work presents a stochastic branching process model of tumour-immune coevolution, incorporating stochastic antigenic mutation accumulation and escape within the cancer cell population. They then used this model to investigate how tumour-immune interactions influence tumour outcome and the summary statistics of sequencing data of bulk and single-cell sequencing of a tumour. The evidence is compelling and the work will be of interest to cancer-immune biology fields. |\n| --- |\n| Abstract The immune system is one of the first lines of defence against cancer. When effector cells attempt to suppress tumour, cancer cells can evolve methods of escape or inhibition. Knowledge of this coevolutionary system can help to understand tumour–immune dynamics both during tumourigenesis and during immunotherapy treatments. Here, we present an individual-based model of mutation accumulation, where random mutations in cancer cells trigger specialised immune responses. Unlike previous research, we explicitly model interactions between cancer and effector cells and incorporate stochastic effects, which are important for the expansion and extinction of small populations. We find that the parameters governing interactions between the cancer and effector cells induce different outcomes of tumour progress, such as suppression and evasion.\u003Cbr>While it is hard to measure the cancer–immune dynamics directly, genetic information of the cancer may indicate the presence of such interactions. Our model demonstrates signatures of selection in sequencing-derived summary statistics, such as the single-cell mutational burden distribution. Thus, bulk and single-cell sequencing may provide information about the coevolutionary dynamics. |\n\nIntroduction  \nThe immune system does not only protect our body from infectious diseases caused by various pathogens, but also gives the first response against threats emerging within the body, such as cancer. Immune cells try to identify and eliminate tumour cells, which may express antigens not found on normal cells. Meanwhile, tumour cells attempt to hide or evade from immune surveillance (Hanahan, 2022) . From an ecological perspective, this antagonistic relationship gives rise to complex dynamics between a tumour and its microenvironment (Dujon et al., 2021; Kareva et al., 2021) . On an evolutionary level, these two cell types, though belonging to the same organism, coevolve, each adapting to genotypic and phenotypic changes in the other population (George and Levine, 2020) . We are interested in the eco-evolutionary dynamics of genotype-specific interactions between cancer and immune cells arising from a continuous introduction of new antigens in the context of immune surveillance and escape.  \nWang et al. eLife 2025;14:RP103970. DOI: [https://doi.org/10.7554/eLife.103970](https://doi.org/10.7554/eLife.103970) 1 of 33  \n Research article Cance","cbCailY536qYSawj","https://ap.wps.com/l/cbCailY536qYSawj","pdf",16993830,33,"English","# Abstract\n# Introduction\n# eLife digest","[{\"question\":\"What core question does the study address about cancer and immunity?\",\"answer\":\"How interactions between cancer cells and immune effector cells evolve during tumour development, specifically whether they leave measurable genetic signatures.\"},{\"question\":\"How does the model describe tumour–immune dynamics?\",\"answer\":\"It uses an individual-based model that accumulates random cancer mutations and explicitly couples cancer and effector cell interactions, including stochastic effects relevant to small populations.\"},{\"question\":\"What evidence does the study propose from sequencing data?\",\"answer\":\"It predicts selection signatures in sequencing-derived summary statistics, such as the single-cell mutational burden distribution, implying bulk and single-cell sequencing can inform coevolutionary dynamics.\"}]","Cancer–immune coevolution dictated by antigenic mutation accumulation | PDF",1790185302,83,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ba67237c0206822f75ebc3418cabb84f.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/25c12367e60b1c21bddaa1ac9bf1f19f.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d05530bbecbbdecc96c8427693d3c932.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d03bce5321c9c7848f8edb8ad82f5bd1.webp",980,1268]